{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-060535","form_type":"8-K","ticker":"SENS","cik":"0001616543","company_name":"Senseonics Holdings, Inc.","filed_at":"2024-05-13T23:59:59+00:00","discovered_at":"2026-05-14T18:03:19.265592+00:00","generated_at":"2026-06-02T02:21:52.279409+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Senseonics Q1 revenue up 22% to $5.1M; net loss $18.9M vs income $1.3M","bullets":["Revenue $5.1M (+22% YoY); U.S. $3.7M (+76%), OUS $1.4M (-30%).","Net loss $18.9M ($0.03 diluted loss) vs net income $1.3M in Q1 2023, driven by non-cash derivative accounting.","First half 2024 revenue outlook unchanged at $10M (~16% growth YoY).","Received iCGM designation for Eversense; FDA 510(k) filed for 365-day system.","Collaboration with Mercy health system to manage 30,000 potential CGM users."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-060535","json":"https://secwatch.observer/filing/0001104659-24-060535.json","markdown":"https://secwatch.observer/filing/0001104659-24-060535.md","text":"https://secwatch.observer/filing/0001104659-24-060535.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924060535/0001104659-24-060535-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924060535/tm2414203d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-02T02:21:52.279409+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"8857d79bbf2f9903bfb643a2b33ea0f64940b126","claim":"Senseonics Holdings, Inc. reported quarter ended March 31, 2024 results: revenue $5.1 million, net income Net loss was $18.9 million, or $0.03 per share, EPS $0.03 per share.","evidence_excerpt":"Total revenue for the first quarter of 2024 was $5.1 million compared to $4.1 million for the first quarter of 2023.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924060535/0001104659-24-060535-index.htm","confidence":0.95,"family_label":"Earnings Releases","details":[{"label":"Period","value":"quarter ended March 31, 2024"},{"label":"Revenue","value":"$5.1 million"},{"label":"Net income","value":"Net loss was $18.9 million, or $0.03 per share"},{"label":"EPS","value":"$0.03 per share"},{"label":"Result","value":"reported results"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}